Niagen Bioscience (NAGE) Deferred Taxes (2011 - 2018)
Niagen Bioscience (NAGE) reported Deferred Taxes of -$16000.0 for Q4 2018, down 100.0% year-over-year from -$inf billion in Q4 2017, and down 100.0% quarter-over-quarter from -$8000.0 in Q3 2018.
Niagen Bioscience (NAGE) Deferred Taxes (2011 - 2018) Analysis & Trends
Niagen Bioscience (NAGE) has 6 years of Deferred Taxes data on file, last reported at -$16000.0 in Q4 2018.
- Deferred Taxes for Q4 2018 came in at -$16000.0, down 100.0% year-over-year; the trailing twelve-month figure through Sep 2019 was -$16000.0 (down 260.0% YoY), and the FY2018 annual result was $2000.0, down 98.89% from the prior year.
- Deferred Taxes eased to -$16000.0 in Q4 2018 per NAGE's latest filing, from -$8000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $321037.0 in Q4 2016 and troughed at -$50000.0 in Q1 2018.
- A 3-year average of $50227.5 and a median of -$8000.0 in 2017 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2016 and 2018: Deferred Taxes jumped 1081.37% in 2016, then tumbled 225.0% in 2018.
- A 3-year view of Deferred Taxes shows it stood at $321037.0 in 2016, then plunged by 102.49% to -$8000.0 in 2017, then plunged by 100.0% to -$16000.0 in 2018.
- Business Quant data shows NAGE's Deferred Taxes at -$16000.0 in Q4 2018, -$8000.0 in Q3 2018, and $76000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -16,000.00 |
| Sep 30, 2018 | -8,000.00 |
| Jun 30, 2018 | 76,000.00 |
| Mar 31, 2018 | -50,000.00 |
| Dec 30, 2017 | -8,000.00 |
| Sep 30, 2017 | 168,000.00 |
| Jul 1, 2017 | -20,000.00 |
| Apr 1, 2017 | 40,000.00 |
| Dec 31, 2016 | 321,037.00 |
| Oct 1, 2016 | 75,977.00 |
| Jul 2, 2016 | 125,514.00 |
| Apr 2, 2016 | -18,857.00 |
| Jan 2, 2016 | -32,713.00 |
| Mar 30, 2013 | -15,621.00 |
| Dec 29, 2012 | -14,849.00 |
| Sep 29, 2012 | -14,849.00 |
| Jun 30, 2012 | -14,223.00 |
| Mar 31, 2012 | -15,811.00 |
| Dec 31, 2011 | -15,039.00 |
| Oct 1, 2011 | -9,977.00 |